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Abstract 
Introduction In 2015, a multi-national randomized controlled phase IV clinical trial of adaptive 
servo-ventilation for the management of heart failure with central sleep apnea was halted in 
progress because more patients in the study group were dying than in the control group. One year 
later, another large clinical trial reported results on the effectiveness of continuous positive 
airway pressure (CPAP) in preventing sudden death and other cardiovascular events such as 
heart attack and stroke in patients with pre-existing vascular disease as well as obstructive sleep 
apnea.  Background Sudden unexpected death has been associated with many types of small and 
non-malignant medullary brain lesions, like demyelination plaques — largely asymptomatic until 
they caused sudden death.  Many such medullary lesions, typically without hemorrhage or mass 
effect, have in themselves been previously considered relatively harmless — in cases where they 
have been known to be present.   
Discussion Why did not the improved pulmonary ventilation and subsequently improved gas 
exchange provided during the CPAP and servo-ventilation clinical trials help to resolve any 
ischemic lesions that may have been present both in the heart and in the medulla, thereby tending 
to normalize interactions between the vagal neural structures and the heart?   CO2 is a potent 
dilator of brain vasculature thereby increasing blood flow to the brain.  When ventilation is 
increased, even if only to improve it back toward normal from a depressed steady-state level, the 
alveolar partial pressure of carbon dioxide is decreased, likely resulting in a converse relative 
vasoconstriction in the brain, thereby reducing blood flow in the brain, especially in watershed 
areas like the solitary tract nucleus. In normal physiology this is demonstrated impressively by 
the ability of hyperventilation to induce loss of consciousness.  
Conclusions The findings of several clinical trials recently reported, taken together with 
neuropathology case studies reported elsewhere, suggest that additional research is warranted in 
regard to the mechanisms by which focal medullary autonomic brain ischemia may be related to 
sudden death in general medical illnesses — and how it may additionally be influenced by 
changes in arterial CO2 levels. 
 
Keywords Heart failure; vagus nerve; ischemia; carbon dioxide; CO2; solitary tract nucleus; 
sleep apnea; brain medulla; vasoconstriction; vasculature; sudden cardiac death; autonomic 
nuclei. 
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1. Introduction 
 
1.1. Ground Zero 
In 2015, a multi-national randomized controlled phase IV clinical trial of adaptive servo-
ventilation (ASV) for the management of heart failure with central sleep apnea (CSA) was halted 
in progress because more patients in the study group were dying than in the control group [1].   It 
seems that more than a few physicians around the globe were stunned and confounded by the 
news. 
The study group of patients had nocturnally been receiving pulses of pressurized air into the 
upper airway, synchronized to discharge during spells of apnea which occurred during sleep and 
which were considered to result from central nervous system causes.   The therapy was simply an 
attempt to replace the patients’ own respiratory efforts, which had intermittently ceased for the 
duration of each apnea spell.  It was surmised that the respiratory therapy would help to maintain 
pulmonary gas exchange that had been impaired as a result of the apnea spells.  It was hoped that 
with more normalized gas exchange, the patients would enjoy a variety of benefits and be less 
likely to experience sudden death — an adverse event that had been recognized to occur at 
greater frequency in patients who had heart failure with central sleep apnea.   To many observers 
the trial results as reported in the New England Journal of Medicine that September 2015 defied 
logic, leading some to question the design, methodology, and execution of the trial — and 
therein spawning a cacophony of letters to the editor [2], and opinion papers in other journals [3-
7].   
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1.2. Grounded Again 
One year later, in 2016, the New England Journal of Medicine [8] reported on another large 
clinical trial that had studied the effectiveness of continuous positive airway pressure (CPAP) in 
preventing sudden death and other cardiovascular events such as heart attack and stroke in 
patients with pre-existing vascular disease as well as obstructive sleep apnea.  The trial 
investigators concluded that CPAP had no such effectiveness; however, the trial was able to 
proceed to completion with both the study group and the control group similarly affected by 
sudden death and other new cardiovascular events.  
 
1.3. Background    
In recent years, sudden unexpected death has been associated with many types of small and 
non-malignant medullary brain lesions, like demyelination plaques — largely asymptomatic until 
they caused sudden death [9-20].  Many such medullary lesions, typically without hemorrhage or 
mass effect, have in themselves been previously considered relatively harmless — in cases where 
they have been known to be present.  Some cases of medullary lesions, not known to be present 
during life, were discovered at autopsy in cases where no other cause of death could be 
identified.   And significantly, in heart failure and in sleep apnea, sudden death has also been 
associated with medullary autonomic ischemic lesions, especially involving the solitary tract 
nucleus [21, 22]. 
Because these latter have been more anatomically specific to a neuronal group than to a 
vascular bed, their reporting authors [21,22] suggested that they are probably not directly caused 
by cerebrovascular disease, or by the defective ventilation of sleep apnea, but rather by highly 
increased sensory afferent vagal stimulation from the heart —which is in turn induced by cardiac 
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ischemia and its resultant worsened cardiac performance, which together may be caused in part 
by the defective ventilation of sleep apnea.  Sensory afferent vagus nerve stimulation terminates 
at the solitary tract nucleus in the medulla, where the increased metabolic requirements 
associated with intense neurotoxic stimulation converge with a limited watershed vasculature to 
contribute to the formation of focal ischemic lesions.  This constellation of events is believed to 
trigger sudden death by a mechanism which is unknown, and some physicians further speculate 
that these events may be arrhythmogenic through the dorsal motor nucleus of the vagus nerve.    
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2. Discussion 
 
2.1. Grounds for Controversy 
Why did not the improved pulmonary ventilation and subsequently improved gas exchange 
provided during the CPAP and servo-ventilation clinical trials help to resolve any ischemic 
lesions that may have been present both in the heart and in the medulla, thereby tending to 
normalize interactions between the vagal neural structures and the heart?    
CO2 is a potent dilator of brain vasculature thereby increasing blood flow to the brain.  When 
ventilation is increased, even if only to improve it back toward normal from a depressed steady-
state level, the alveolar partial pressure of carbon dioxide is decreased, likely resulting in a 
converse relative vasoconstriction in the brain, thereby reducing blood flow in the brain, 
especially in watershed areas like the solitary tract nucleus. In normal physiology this is 
demonstrated impressively by the ability of hyperventilation to induce loss of consciousness. In 
patients with heart failure and sleep apnea, arterial carbon dioxide may not seem adequately 
reduced by externally applied respiratory therapy to cause even relative vasoconstriction in the 
brain, but a small reduction in carbon dioxide may be very significant, statistically, over a 
population of patients in the overall context of pathophysiology rather than normal physiology.  
One can speculate that when blood flow is decreased to an area that is already ischemic like the 
solitary tract nucleus, the ischemia will likely worsen and cause secondary effects related to its 
normal function.  In the case of the solitary tract nucleus, this would include regulation of heart 
rate, rhythmicity, and contractility through its efferent output pathway via the dorsal motor 
nucleus of the vagus nerve.        
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Evidence of this insidious influence of changing carbon dioxide levels may be seen in the 
somewhat different results obtained from the two clinical trials [2,8] using different forms of 
respiratory therapy. In the CPAP trial [8], the patients’ airways were simply maintained in a 
more open position, allowing improved ventilation entirely through the patients’ own breathing 
efforts. In the servo-ventilation trial, airway maintenance was achieved together with mechanical 
inspiratory assistance.    In the servo-ventilation study group, the degree to which pulmonary 
ventilation and thus gas exchange were assisted was significantly greater than in the CPAP study 
group.  In the CPAP study group there was no net change in the incidence of sudden death 
compared to the control group.   In contrast, the servo-ventilation trial was stopped when more 
patients in the study group were dying compared to the control group.   Intended to improve 
oxygenation and gas exchange in ischemic myocardial tissue, it is possible that servo-ventilation 
may have paradoxically and perversely worsened circulation in ischemic medullary brain tissue 
which is probably just as important in causing sudden death, and where the damaging effects of 
decreased CO2 levels seem to outweigh any beneficial effects of indirectly increased 
oxygenation.         
In 2017, Hofmann et al [23] reported some potentially corroborating information from 
another clinical trial.  Oxygen administration for patients with acute myocardial infarction was 
shown to be unhelpful as a routine therapy in the absence of specific laboratory data in an 
individual patient showing hypoxemia.   This trial conclusion may have some general relevance 
to heart failure where myocardial ischemia or infarction sometimes plays a role — as either an 
etiology or a complication.   And although patients in the CPAP and adaptive-servo trials did not 
necessarily receive supplemental oxygen, it was probably presumed by many observers that 
myocardial oxygenation would be indirectly improved by normalized ventilation and that this 
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would affect outcomes favorably.   To such observers, the two sleep apnea trials [2,8] may have 
revealed that myocardial oxygenation was not generally as critical a parameter in patient 
management as was carbon dioxide in the brain.   
 
2.2. Gaining Ground    
Notwithstanding the results of recent trials of respiratory therapy [2,8,23], Shen et al [24] 
recently reported that from 1995 to 2014 the rate of sudden death in heart failure patients actually 
declined substantially — apparently due to the gradual introduction of medications controlling 
such circulatory factors as blood pressure, cardiac rate, and myocardial contractility [24]. This 
meta-analysis of a dozen clinical trials, overlapping each other over two decades, offers hope that 
additional improvements can be made in the future — and it may offer some general direction in 
how best to approach future therapy.   
Why is the risk of sudden death in heart failure patients, frequently with ischemic cardiac 
disease and sleep apnea, reduced by circulatory improvement but not by ventilatory 
improvement when deficiencies in both areas seem clearly to be contributors to sudden death? It 
is conceivable that the answer may lie in the largely unrecognized role of the solitary tract 
nucleus of the brain medulla, which seems to develop its own ischemic lesions due to afferent 
neurotoxic input through the vagus nerve in the context of either ischemic cardiac disease or 
sleep apnea [21,22].   Medications which improve blood circulation influence the brain in largely 
the same manner that they influence the rest of the body.   But respiratory therapy, which directly 
improves gas exchange in the heart and lungs, collides with counter-current mechanisms in the 
brain which result in decreased blood flow.   Improvements in systemic circulation [24] (and 
probably medullary brain circulation) seemed to reduce the risk of sudden death in heart failure 
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patients where respiratory therapy did not [2,8].    Once thought to involve only a tiny subset of 
neurology patients [9-15], sudden death related to tiny medullary brain lesions may possibly 
involve a large segment of the general medical population — much of which is not typically 
considered to have neurological disease. 
A thorny lingering subset in the mystery of unexpected sudden deaths are athletes who are 
considered healthy, only to drop dead during a competitive sporting event [25]. The clinico-
pathological common denominator in all of these sudden deaths could be exercise-induced 
tachycardia which may occasionally cause transient ischemia of the heart and solitary tract 
nucleus, not readily apparent at general autopsy.  
  
 
2.3. Common Ground        
It is interesting that several years prior to the publication of any of these clinical trial results 
[2,8,23-25], the American Heart Association revised its guidelines for cardio-pulmonary 
resuscitation (CPR) outside of a hospital setting — to minimize mouth-to-mouth ventilation and 
become ‘Hands-only CPR’, focusing largely on manual chest compressions.    
Patients experiencing cardiac arrest are physiologically compromised in a manner similar to 
that of patients with heart failure and sleep apnea — only to a much more severe degree.   Blood 
circulation through the heart, lungs, and brain has essentially stopped.   The solitary tract nucleus 
is severely ischemic, yet its capacity for blood flow is preserved to a large extent by the 
vasodilation in the brain associated with dramatically increased carbon dioxide levels.   
The challenge of resuscitation efforts is to improve circulation and oxygenation in all vital 
organs while blood flow in the brain (and in the solitary tract nucleus) experiences a response to 
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carbon dioxide levels which runs counter-current to that of the other organs.   Four clinical trials 
published from 2000 to 2015 [26-29] have shown no difference in clinical outcomes between 
patients receiving the more easily administered Hands-only CPR and those receiving both chest 
compressions and mouth-to-mouth ventilation — possibly showing again that the detrimental 
effects of CO2-related vasoconstriction in the medulla neutralize or out-weigh the beneficial 
effects of improved myocardial oxygenation.    In 2017, the American Heart Association 
published findings from a nation-wide data-base of out-of-hospital resuscitations in Japan 
between 2007 and 2012 to confirm its recommendation for Hands-only CPR initiated in 2010 
[30].       
We observed from recent clinical trials [2,8,24] that in managing patients with heart failure 
and sleep apnea, just as in managing patients with acute cardiac arrest outside of a hospital 
setting [26-29], the approach that has actually worked to improve patient outcomes is 
maximizing circulatory assistance and minimizing respiratory assistance.   
Figure 1 shows the relationship between treated and untreated sleep apnea. A patient with 
established sleep apnea since an earlier time (solid arrows) receives respiratory therapy at a later 
time (broken arrows).  
 
We believe that all of the relevant clinical trials and analyses reported in the New England 
Journal of Medicine [2,8,23-29] were fundamentally sound in their design, methodology, and 
execution; and that the results were fundamentally correct.  But how can this odd and disparate 
stratification of data be definitively reconciled unto itself?  The topic remains wide open [31]. 
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3. Conclusions 
 
In this paper, we conclude that the findings of several clinical trials recently reported in the 
New England Journal of Medicine [2,8,23-29], taken together with neuropathology case studies 
reported elsewhere [21,22], suggest that additional research is warranted in regard to the 
mechanisms by which focal medullary autonomic brain ischemia may be related to sudden death 
in general medical illnesses — and how it may additionally be influenced by changes in arterial 
CO2 levels. 
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Figure Legend 
 
Figure 1. 
Diagram of the relationship between the treated and untreated sleep apnea. A patient with 
established sleep apnea since an earlier time (solid arrows) receives respiratory therapy at a later 
time (broken arrows).  
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Highlights 
 
 In 2015, a phase IV clinical trial of adaptive servo-ventilation for heart failure with 
central sleep apnea was halted.  
 Another large clinical trial had studied the effectiveness of continuous positive airway 
pressure (CPAP) in preventing sudden death. 
  Sudden unexpected death has been associated with many types of small medullary brain 
lesions, largely asymptomatic. 
 When ventilation is increased, the alveolar partial pressure of CO2 is decreased, likely 
resulting in a relative vasoconstriction in the brain.  
 Clinical trials suggest that additional research is warranted in regard to the mechanisms 
by which focal medullary autonomic brain ischemia may be related to sudden death 
 Sudden death may additionally be influenced by changes in arterial CO2 levels. 
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